"Herpes Zoster Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An attenuated vaccine used to prevent and/or treat HERPES ZOSTER, a disease caused by HUMAN HERPESVIRUS 3.
Descriptor ID |
D053061
|
MeSH Number(s) |
D20.215.894.899.290.130.400
|
Concept/Terms |
Herpes Zoster Vaccine- Herpes Zoster Vaccine
- Vaccine, Herpes Zoster
- Zoster Vaccine
- Vaccine, Zoster
- Shingles Vaccine
- Vaccine, Shingles
|
Below are MeSH descriptors whose meaning is more general than "Herpes Zoster Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Herpes Zoster Vaccine".
This graph shows the total number of publications written about "Herpes Zoster Vaccine" by people in this website by year, and whether "Herpes Zoster Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2017 | 2 | 1 | 3 |
2018 | 2 | 0 | 2 |
2019 | 1 | 0 | 1 |
2021 | 3 | 0 | 3 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Herpes Zoster Vaccine" by people in Profiles.
-
Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States. Vaccine. 2022 11 28; 40(50):7187-7190.
-
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis. Am J Hematol. 2022 01 01; 97(1):90-98.
-
Corneal Allograft Rejection Associated With Herpes Zoster Recombinant Adjuvanted Vaccine. Cornea. 2022 Jun 01; 41(6):772-774.
-
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults = 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Hum Vaccin Immunother. 2021 07 03; 17(7):2050-2057.
-
Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax? in healthy adults aged 50 years and older. Vaccine. 2019 06 12; 37(27):3605-3610.
-
Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study. J Acquir Immune Defic Syndr. 2018 12 01; 79(4):527-533.
-
Reactivation of Herpes Zoster Stromal Keratitis After HZ/su Adjuvanted Herpes Zoster Subunit Vaccine. Ophthalmology. 2018 11; 125(11):1682.
-
Herpes Zoster During Immunosuppressive Therapy For Autoimmune Diseases. J Ayub Med Coll Abbottabad. 2017 Jul-Sep; 29(3):481-485.
-
Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults. J Immunol. 2017 07 15; 199(2):604-612.
-
Metabolic Phenotypes of Response to Vaccination in Humans. Cell. 2017 May 18; 169(5):862-877.e17.